Orna Proves Concept in Preclinical Oncology and DMD Models

May 16, 2022 – Orna Therapeutics stormed out of the gate in February 2021 with $100 million in financing. Since then, the Cambridge, MA-based company has done anything but spin in circles. Orna made its way onto BioSpace’s list of Top Life Sciences Startups to Watch in 2022 list and on Monday, it gave investors something new: validation.